Clinical Trials
30 trialsEvaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
Ottawa Hospital Research Institute
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
OHSU Knight Cancer Institute
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
Bayer
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
FC-VE
University Hospital, Linkoeping
Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer
Ohio State University Comprehensive Cancer Center
A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
Astellas Pharma Inc
Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
Mayo Clinic
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
Brigham and Women's Hospital
ODYSSEY
Guerbet
CUT-less
University of Roma La Sapienza
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
OHSU Knight Cancer Institute
Gadopiclenol in Contrast Enhanced MRI of the Prostate
Columbia University
CANIQOL
Centre Francois Baclesse
COBRA-NMIBC
Aarhus University Hospital
CABOLD
Gustave Roussy, Cancer Campus, Grand Paris
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
Peking University First Hospital
GAINPCCONTROL
Hamilton Health Sciences Corporation
ITALIC-RCC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ENABLE
Deventer Ziekenhuis
Preop Laxatives in Robotic Urologic Surgery
University of Iowa
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Novartis
PEHAB-II
The Netherlands Cancer Institute
ARCO2
Brazilian Institute of Robotic Surgery
REINFORCE
Rigshospitalet, Denmark
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
VA Greater Los Angeles Healthcare System
ADAPT-PSA
Albany Medical College
The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer
Cairo University
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
Konkuk University Medical Center
PROMED
Turku University Hospital